Final Factsheet as of 27 July 2015 Best-Of Bonus Certificate
Nestlé, Roche, Novartis
The Best-of Bonus Certificate offers 100% participation in the positive performance of the best-performing Reference Share (i.e. the Reference Share with the best performance on the Final Fixing Date with respect to the Initial Fixing Date), subject to a minimum repayment of the Bonus Level, as long as all Reference Shares trade above their Barrier throughout the lifetime of the product. If not, the invested capital will be converted into the predetermined number of shares of the worst-performing Reference Share (i.e. the Reference Share with the worst performance on the Final Fixing Date with respect to the Initial Fixing Date). This product does not constitute a participation in a collective investment scheme within the meaning of the Swiss Federal Act on Collective Investment Schemes (CISA) and is therefore not subject to authorization or supervision by the Swiss Financial Market Supervisory Authority (FINMA). Investors bear the issuer risk.
Underlyings (Basket) Bloomberg Ticker Initial Level Barrier No. of Shares Exchange
Nestlé Ltd registered share NESN VX CHF 72.05 CHF 48.2735 13.8793 SIX Swiss Exchange
Roche Holding Ltd dividend-right certificate ROG VX CHF 277.30 CHF 185.7910 3.6062 SIX Swiss Exchange
Novartis Inc. registered share NOVN VX CHF 98.65 CHF 66.0955 10.1368 SIX Swiss Exchange
Fixed Key Information Final Redemption Scenarios
Issuer Credit Suisse AG, acting through its Nassau Branch, Nassau, If none of the Reference Shares has ever traded at or Bahamas (Rating: Moody's: A1 / Standard & Poor's: A) Bonus Level below its Barrier, the investor will receive the A Initial Level Denomination plus 100% of the positive performance of Issue Price CHF 1'000 the best-performing Reference Share on the Final Barrier Fixing Date, calculated from its Initial Level. However, Denomination CHF 1'000 the investor will receive a minimum repayment of the
Bonus Level. Initial Basket Level 100% (all Underlyings are equally weighted)
If at least one Underlying has ever traded at or below its Bonus Level CHF 1'000 (100% of the Denomination) Barrier, the investor will receive the predetermined Initial Level number of shares of the worst-performing Underlying. Barrier 67% of the Initial Level (observed continuously) B Fractions will not be cumulated and will be paid in Barrier Initial Fixing Date 24 July 2015 cash.
Payment Date 31 July 2015
Main Benefits Main Risks* Final Fixing Date 24 July 2018 If none of the Reference Shares Issuer Risk and Market Risk Final Redemption Date 31 July 2018 has ever traded at or below its No Capital Protection Barrier, you will participate in the
Valor / ISIN 24 874 896 / CH0248748961 positive performance of the best- performing Reference Share (best- Telekurs Ticker CSIXZ of) at 100%, and in this case the final redemption amount is at least Capital Protection No equal to the Bonus Level. Market Expectation Sideways to positive One of the Underlyings needs to fall by 33% or more from its Initial Sales / USA, US persons, UK, EEA, Hong Kong, Level before your invested capital Offering Restrictions Singapore, Bahamas (see Page 2) may be subject to a loss. * see the detailed description of the Risks on Page 2
This document represents marketing material and only outlines certain key features of the product. Page 1/2
Important Notices to Investors Further Investment Considerations
Issuer Risk Tax Treatment in Switzerland This product is a type of debt instrument, which is a loan to the Issuer. You No Swiss withholding tax (Verrechnungssteuer). Secondary market transactions bear the risk that Credit Suisse AG, acting through its Nassau Branch, Nassau, are subject to Swiss securities transfer stamp tax (0.15%) for Swiss resident Bahamas, as the Issuer may not be able to meet its payment obligation to you. investors. For Swiss resident private investors Swiss income tax is due on the Therefore, if the Issuer defaults or becomes insolvent, your investment may be difference between the theoretical values of the money market component at the at risk and you could lose some or all of the capital invested. time of purchase/sale and issuance/redemption, respectively, of the product as Market Risk computed by the SIX Telekurs Ltd Bondfloor Pricing System. This product The performance of this product depends on the general global economic classifies as transparent and IUP (Interest Unique Predominant). The payments situation along with the political and economic factors in the specific countries. made by Swiss paying agents to EU resident individuals will not be subject to EU In particular, any changes in market prices (e.g., interest rates, stock prices, withholding tax. foreign exchange rates or commodity prices) can have a negative effect on the Bondfloor (at issuance): 100% (the internal rate of return (IRR) at issuance is valuation of the Underlyings or the product. Therefore, if you choose to sell the 0%). product prior to the Final Redemption Date, it may result in a poor return which The delivery of the Underlyings, if any, is subject to securities transfer stamp tax. may include loss to your capital. Complex Product / Investor Responsibility No Capital Protection This product is a complex securitized derivative and involves a high degree of risk. There is no capital protection with this investment. Depending on the It is intended only for investors who (a) have prior knowledge or experience of performance of the Underlyings, the final redemption amount may be less than this product or (b) take steps to familiarize themselves with the features and risks the invested capital or in the worst case you may lose all of the capital you have of this product, so as to determine if this product suits their investment invested. objectives, and independently assess (with their independent professional Currency Risk advisors if necessary) the specific risks (maximum loss, currency risks, etc.) and If an investment is denominated in a currency other than your base currency, the legal, regulatory, credit, tax, accounting consequences and any foreign changes in the rate of exchange may have an adverse effect on value, price or exchange restrictions or exchange control requirements before making any income. investment decision. Investors must understand and be capable of assuming all risks involved. No Dividend Entitlement In addition to carefully reviewing this document, you should review In case this product is linked to the performance of specific shares, you are not the “Special Risks in Securities Trading” risk disclosure brochure (which entitled to any dividend payments, as you are not a shareholder. is available on the Swiss Bankers Association's website: Secondary Market www.swissbanking.org/en/home/shop.htm). The Issuer's product documen- If you try to sell this product, you may not be able to find a buyer or the sale tation contains additional terms, risks and information about the Issuer. price may be below the purchase price. Any information and explanation (written or oral) relating to this product provided Redemption Risk by Credit Suisse AG should not be considered as investment, legal, accounting The product terms may permit the Issuer to redeem the product earlier upon or tax advice or a recommendation to invest in this product. Credit Suisse AG the occurrence of certain tax events or change of law at a value to be makes no representation as to the suitability of any product for any particular determined by the Issuer. investor or as to the future performance of any product. No communication (written or oral) received from Credit Suisse AG shall be deemed to be an Purpose of this Document assurance or guarantee as to the expected results of this product. This document represents marketing material and only outlines certain key features of the product. It is neither a simplified prospectus as stated in Art. Potential Conflicts / Compensation 5 of the Swiss Federal Act on Collective Investment Schemes nor a prospectus In connection with this product, the Issuer and/or its affiliates may pay to third in accordance with Art. 652a / Art. 1156 of the Swiss Code of Obligations. parties, including affiliates, remunerations that may be factored into the terms of You should refer to the Issuer's product documentation which constitutes the this product. The Issuer and/or its affiliates may also offer such remunerations to only legally binding terms for this product and contains further elaboration on third parties in the form of a discount on the price of the product. Receipt or risk factors. The simplified prospectus according to Swiss law can be obtained potential receipt of such remunerations may lead to a conflict of interests. from www.credit-suisse.com/derivatives. Credit Suisse AG does not make any Internal revenue allocation may lead to a similar effect. Further information can representation as to the accuracy or completeness of this document and be found in the simplified prospectus. Finally, third parties or the investor’s bank assumes no liability for losses and tax implications arising from the use hereof. may impose a commission/brokerage fee in connection with the purchase/sale This product does not constitute a participation in a collective investment of or subscription to the product. Investors may request further information from scheme. Therefore, it is not supervised by the Swiss Financial Markets their bank/relationship manager. Supervisory Authority (FINMA) and the holder of this product does not benefit Sales and Offering Restrictions from the specific investor protection provided under the Swiss Federal Act on US: Neither this document nor any copy may be sent, taken into or distributed in Collective Investment Schemes (CISA). This document is not the result of the United States or to any U.S. person (within the meaning of Regulation S financial analysis or research and therefore is not subject to the “Directives on under the US Securities Act of 1933, as amended). This product has not been the Independence of Financial Research” of the Swiss Bankers Association. and will not be registered under the U.S. Securities Act of 1933, as amended This document does not constitute an offer or invitation to enter into any type of (the “Act”) and may not be offered, sold or transferred within the United States or financial transaction. The Issuer has no obligation to issue this product. Where to, or for the account or benefit of, any U.S. persons (as defined in Regulation S not explicitly otherwise stated, the Issuer has no duty to invest in the under the Act) unless an exemption from such registration is available. Underlyings and investors have no such recourse. EEA: In relation to each Member State of the European Economic Area (EEA) No Financial Advisory / Fiduciary that has implemented the Prospectus Directive (Directive 2003/71/EC) and the The Issuer is acting solely as an arm's length contractual counterparty and Amending Directive (Directive 2010/73/EU), the product may not be sold or neither the Issuer nor any affiliate is acting as the financial advisor or fiduciary offered, or any offering materials relating thereto may not be distributed to the of the investor unless it has agreed to do so in writing. By purchasing this public (within the meaning of the Prospectus Directive) in that relevant Member product, investors acknowledge that they are not relying on the views or advice State, except during circumstances which do not require the publication of a or any information of the Issuer or its affiliates in respect of the purchase of this prospectus pursuant to the Prospectus Directive. Such circumstances would product. include situations where the total consideration per investor is greater than or
equal to EUR 100'000 or currency equivalent, or where the denomination of the product is greater than or equal to EUR 100'000. Other: Neither this document nor any copy may be sent in any other jurisdiction except in compliance with the applicable laws thereof. For additional sales/offering restrictions please refer to the legally binding documentation.
Credit Suisse AG Telephone: +41 (0)44 335 76 00 - Please note that conversations on this line P.O. Box are recorded. We will assume your consent. CH-8070 Zurich Internet: www.credit-suisse.com/derivatives
© 2015 Credit Suisse Group AG and/or its affiliates. All rights reserved. This document may not be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, either in whole or in part, without the prior written permission of Credit Suisse Group AG. Page 2/2